Skip to main content

Psoriatic Arthritis

ALN
The new treatment option is the first fully human anti-TNF-α biologic agent administered via intravenous infusion approved for pediatric use in both active pJIA and active PsA.
Rheumatology Consultant
In this podcast, Ana-Maria Orbai, MD, MHS, talks about the interchangeability between the HAQ-DI and PROMIS-PF in the measurement of minimal disease activity among patients with psoriatic arthritis and how it may influence your practice.
Rheumatology Consultant
Dactylitis is a hallmark of psoriatic arthritis. To better detect inflammation of anatomical structures in the fingers and to monitor the effects of therapy, a group of researchers developed a new scoring system. Alen Zabotti, MD, answered our questions about the DACTOS score that he and his colleagues created.
Rheumatology Consultant
Extra-articular manifestations can occur in all forms of inflammatory arthritis. Which manifestations are most common among your patients with psoriatic arthritis? Take our poll to voice your opinion!
ALN
Obesity was associated with an increased risk of psoriatic arthritis onset, which suggests that lifestyle changes may reduce the risk of this comorbidity among patients with psoriasis, according to a recent study.
Back to Top